Trade Mark Journal No.2021/053 31 December 2021

WO0000001629954 (35,36,41)

Office of origin: Switzerland

Date of International Registration:16 September 2021
Date of designation in the UK: 16 September 2021
Image for mark 1629954_TIF COVAX

International priority date claimed: 10 May 2021 (Switzerland) (764624)
Class 35
Advertising services, namely, public advocacy for promoting public awareness of public health issues, vaccine benefits, vaccine hesitancy, the health risks of an under-immunized community, and equitable access to vaccines; advertising to promote public awareness of public health issues, the benefits of vaccines, vaccine hesitancy, the health risks of an under-immunized community, and equitable access to vaccines; procurement services for others, namely, purchase of vaccines.
Class 36
Charitable fundraising services, namely, fundraising and distribution of donations for the purchase and supply of medical goods and services; financial services, namely, investment of funds for research, development, manufacturing and distribution of vaccines; insurance services, namely, settlement of civil liability claims; claims processing in the field of insurance, namely, processing settlement claims and insurance authorization information and support.
Class 41
Publication of texts and magazines, videos and articles in the field of public health, vaccine benefits, vaccine hesitancy, the health risks of an under-immunized community, and equitable access to vaccines; education, namely, providing training and seminars in the field of vaccines and medicines; organization of educational and informational meetings and conferences in the field of vaccines and medicines; providing information in the field of public health, vaccine benefits, vaccine hesitancy, the health risks of an under-immunized community, and equitable access to vaccines via an online website.

GAVI Alliance

Representative: K&L Gates LLP, 925 Fourth Avenue, Suite 2900, Seattle WA 98104, UNITED STATES OF AMERICA